Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease

Journal of Virology

Volumn 86, Issue 19, 2012, Pages 10597-10605

  Vincent, Amy L ^a   Ma, Wenjun ^a,b,e   Lager, Kelly M ^a   Richt, Jürgen A ^a,e   Janke, Bruce H ^b   Sandbulte, Matthew R ^b   Gauger, Philip C ^a,b   Loving, Crystal L ^a   Webby, Richard J ^c   García Sastre, Adolfo ^d  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; MATERNAL ANTIBODY; TX98 VIRUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENIC VARIATION; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION; IMMUNOGENICITY; INFLUENZA VIRUS A H3N2; LUNG; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROVOCATION TEST; SAFETY; SWINE; TRACHEA; VACCINATION; VACCINE ASSOCIATED ENHANCED RESPIRATORY DISEASE; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; DOGS; HEMAGGLUTINATION INHIBITION TESTS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; LUNG; MUCOUS MEMBRANE; RESPIRATORY TRACT INFECTIONS; SWINE; VACCINES, ATTENUATED;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 84869054575     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01439-12     Document Type: Article

References (29)

1. Bikour MH, Cornaglia E, Elazhary Y. 1996. Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs. Can. J. Vet. Res. 60:312-314.
2. Choi YK, Goyal SM, Joo HS. 2004. Evaluation of transmission of swine influenza type A subtype H1N2 virus in seropositive pigs. Am. J. Vet. Res. 65:303-306.
3. Delgado MF, et al. 2009. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat. Med. 15:34-41.
4. Gauger PC, et al. 28 March 2012. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus. Vet. Pathol. doi:10.1177/0300985812439724.
5. Gauger PC, et al. 2011. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 29:2712-2719.
6. Halbur PG, et al. 1995. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet. Pathol. 32:648-660.
7. Kappes MA, et al. 2012. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs. Vaccine 30:280-288.
8. Kitikoon P, et al. 2006. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. Vet. Immunol. Immunopathol. 112:117-128.
9. Lee JH, Gramer MR, Joo HS. 2007. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant. Can. J. Vet. Res. 71:207-212.
10. Loeffen WL, Heinen PP, Bianchi AT, Hunneman WA, Verheijden JH. 2003. Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infection with an influenza H1N1 virus. Vet. Immunol. Immunopathol. 92:23-35.
11. Lorusso A, et al. 2011. Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008. J. Gen. Virol. 92: 919-930.
12. Ma W, Richt JA. 2010. Swine influenza vaccines: current status and future perspectives. Anim. Health Res. Rev. 11:81-96.
13. Masic A, Booth JS, Mutwiri GK, Babiuk LA, Zhou Y. 2009. Elastasedependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs. J. Virol. 83:10198-10210.
14. Masic A, et al. 2010. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Vaccine 28:7098-7108.
15. Monsalvo AC, et al. 2011. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 17:195-199.
16. Olsen CW. 2002. The emergence of novel swine influenza viruses in North America. Virus Res. 85:199-210.
17. Palmer DF, Coleman MT, Dowdle WD, Schild GO. 1975. Advanced laboratory techniques for influenza diagnosis. Immunology series no. 6. U.S. Department of Health, Education, and Welfare, Washington, DC.
18. Pena L, et al. 2011. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J. Virol. 85:456-469.
19. Pomorska-Mol M, Markowska-Daniel I, Pejsak Z. 2010. Evaluation of humoral and antigen-specific T-cell responses after vaccination of pigs against pseudorabies in the presence of maternal antibodies. Vet. Microbiol. 144:450-454.
20. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg. 27:5.
21. Renshaw HW. 1975. Influence of antibody-mediated immune suppression on clinical, viral, and immune responses to swine influenza infection. Am. J. Vet. Res. 36:5-13.
22. Richt JA, et al. 2003. Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. J. Clin. Microbiol. 41:3198-3205.
23. Richt JA, et al. 2006. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. J. Virol. 80: 11009-11018.
24. Solorzano A, et al. 2005. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J. Virol. 79:7535-7543.
25. Vincent AL, Lager KM, Janke BH, Gramer MR, Richt JA. 2008. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vet. Microbiol. 126:310-323.
26. Vincent AL, et al. 2007. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 25: 7999-8009.
27. Webby RJ, Rossow K, Erickson G, Sims Y, Webster R. 2004. Multiple lineages of antigenically and genetically diverse influenza A virus cocirculate in the United States swine population. Virus Res. 103:67-73.
28. Wittmann G, Ohlinger V. 1987. Aujeszky's disease vaccination and infection of pigs with maternal immunity: effects on celland antibodymediated immunity. Arch. Virol. 92:87-101.
29. Zhou NN, et al. 1999. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J. Virol. 73:8851-8856.